Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin E M Noble

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Acta Crystallographica. Section D, Structural Biology|November 2, 2022
Exiting the tunnel of uncertainty: crystal soak to validated hitMathew P Martin, Martin E M Noble
Bioinformatics (Oxford, England)|April 28, 2005
Dynamite extended: two new services to simplify protein dynamic analysisC Paul Barrett, Martin E M Noble
The Journal of Biological Chemistry|February 8, 2005
Molecular motions of human cyclin-dependent kinase 2C Paul Barrett, Martin E M Noble
Biochemical Society Transactions|July 19, 2013
Structural characterization of the cyclin-dependent protein kinase familyJane A Endicott, Martin E M Noble
Biochimica Et Biophysica Acta|October 14, 2009
Recent developments in cyclin-dependent kinase biochemical and structural studiesAude Echalier, Jane A Endicott, Martin E M Noble
Annual Review of Biochemistry|April 10, 2012
The structural basis for control of eukaryotic protein kinasesJane A Endicott, Martin E M Noble, Louise N Johnson
Science (New York, N.Y.)|March 20, 2004
Protein kinase inhibitors: insights into drug design from structureMartin E M Noble, Jane A Endicott, Louise N Johnson
Current Opinion in Drug Discovery & Development|September 2, 2004
The role of structure in kinase-targeted inhibitor designDavid J Pratt, Jane A Endicott, Martin E M Noble
Essays in Biochemistry|November 10, 2017
Structure-based discovery of cyclin-dependent protein kinase inhibitorsMathew P Martin, Jane A Endicott, Martin E M Noble
Trends in Biochemical Sciences|February 20, 2026
Diversity in CDK structural mechanisms of regulation and drug discovery opportunitiesRhianna J Rowland, Martin E M Noble, Jane A Endicott
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Acta Crystallographica. Section D, Structural Biology|November 2, 2022
Exiting the tunnel of uncertainty: crystal soak to validated hitMathew P Martin, Martin E M Noble
Bioinformatics (Oxford, England)|April 28, 2005
Dynamite extended: two new services to simplify protein dynamic analysisC Paul Barrett, Martin E M Noble
The Journal of Biological Chemistry|February 8, 2005
Molecular motions of human cyclin-dependent kinase 2C Paul Barrett, Martin E M Noble
Biochemical Society Transactions|July 19, 2013
Structural characterization of the cyclin-dependent protein kinase familyJane A Endicott, Martin E M Noble
Biochimica Et Biophysica Acta|October 14, 2009
Recent developments in cyclin-dependent kinase biochemical and structural studiesAude Echalier, Jane A Endicott, Martin E M Noble
Annual Review of Biochemistry|April 10, 2012
The structural basis for control of eukaryotic protein kinasesJane A Endicott, Martin E M Noble, Louise N Johnson
Science (New York, N.Y.)|March 20, 2004
Protein kinase inhibitors: insights into drug design from structureMartin E M Noble, Jane A Endicott, Louise N Johnson
Current Opinion in Drug Discovery & Development|September 2, 2004
The role of structure in kinase-targeted inhibitor designDavid J Pratt, Jane A Endicott, Martin E M Noble
Essays in Biochemistry|November 10, 2017
Structure-based discovery of cyclin-dependent protein kinase inhibitorsMathew P Martin, Jane A Endicott, Martin E M Noble
Trends in Biochemical Sciences|February 20, 2026
Diversity in CDK structural mechanisms of regulation and drug discovery opportunitiesRhianna J Rowland, Martin E M Noble, Jane A Endicott
Pageof 9